Rejected from Nature Communications? The 7 Best Journals to Submit Next

Nature Communications covers all natural sciences, which means your paper competed against submissions from every scientific discipline. The editorial bar is "significant advance in the specific field," not "important for all of science" (that's Nature itself).

Common rejection patterns

"The advance is incremental." Your paper extends existing knowledge but doesn't change how the field thinks about the topic. Nature Communications wants papers that shift the conversation, even within a narrow field.

"Methodology concerns." The experimental design has gaps, the statistics are questionable, or the controls are insufficient. Nature Communications uses professional editors and external reviewers who flag methodological issues early.

"The work is sound but better suited to a specialty journal." Your paper advances a specific field but Nature Communications' general readership won't engage with it. This isn't a criticism. It's a scope redirect.

"Insufficient novelty for this journal." The results confirm what the field expected. Confirmatory studies, even large ones, face an uphill battle at Nature Communications.

Nature Communications editors can transfer to:

• Communications Biology (IF ~5) - Life sciences
• Communications Chemistry (IF ~6) - Chemistry
• Communications Physics (IF ~5) - Physics
• Communications Medicine (IF ~5) - Clinical/medical
• Scientific Reports (IF ~4) - Broad, sound science

These aren't consolation prizes for every situation, but they're indexed, peer-reviewed, and widely read. Scientific Reports in particular publishes over 20,000 papers per year and provides a rapid path to publication for technically sound work.

1. PNAS

PNAS is Nature Communications' closest analogue in scope: it publishes across all sciences with a ~15% acceptance rate. PNAS values methodological rigor and scientific completeness without requiring the narrative novelty that Nature Communications demands.

If Nature Communications said your paper was "sound but not sufficiently novel," PNAS may disagree. The journal is more receptive to well-executed studies that confirm or extend important findings, and it publishes more methods-oriented and data-rich papers than Nature Communications typically does.

Best for: Well-executed research across any discipline where rigor matters more than narrative surprise.

2. Science Advances

Science Advances shares Nature Communications' broad-scope, open-access model. The IF (~12) is slightly lower, but the readership overlaps. Science Advances uses academic editors (working scientists) rather than professional editors, which gives the review process a different character.

If Nature Communications rejected your paper for "insufficient advance," Science Advances may see it differently because different editors, different perspective, different day. Interdisciplinary papers sometimes find a warmer reception at Science Advances.

Best for: Interdisciplinary research, methods papers, and science that bridges traditional disciplinary boundaries.

3. eLife

eLife's "publish, then curate" model eliminates the binary accept/reject decision after review. If your paper passes peer review, it's published with the reviews attached. This radical transparency means the community judges the work in context rather than through an editor's single decision.

For papers that Nature Communications rejected based on subjective novelty judgments, eLife's model may be appealing. The tradeoff is that eLife's prestige signal is still evolving as hiring committees adapt to the new model.

Best for: Biology papers where you want transparent review, rapid publication, and community-judged quality.

4. Cell Reports

For life science papers, Cell Reports offers the Cell Press editorial infrastructure with a ~25% acceptance rate. The journal publishes across all of biology and doesn't require the field-level advance that Nature Communications demands. If your paper is technically sound biology with clear conclusions, Cell Reports is a strong fit.

Best for: Life science research across all subfields with solid but not transformative findings.

5. PLOS Biology

PLOS Biology publishes biological research with broad implications. The journal values open data, reproducibility, and strong methodology. If your paper emphasizes these qualities and Nature Communications' rejection was about novelty rather than rigor, PLOS Biology may be receptive.

Best for: Biology with broad implications, open science, reproducibility-focused research.

6. Advanced Science

For materials science, chemistry, nanotechnology, and engineering papers, Advanced Science (Wiley) has built a strong reputation with an IF around 14. If Nature Communications rejected your physical sciences paper, Advanced Science reaches the right interdisciplinary audience.

Best for: Materials science, nanotechnology, chemistry, and interdisciplinary physical science.

7. Your top field-specific journal

Sometimes the best move after a Nature Communications rejection is to go to the top journal in your specific field. JACS for chemistry (IF ~15), Circulation for cardiology (IF ~39), EMBO Journal for molecular biology (IF ~11), Nature Structural and Molecular Biology for structural work (IF ~12). These journals' editors are experts in your area and may value your contribution more than a generalist editor would.

Best for: Any paper where the contribution is primarily important within one discipline.

Desk-rejected for "insufficient novelty"? Try PNAS (different novelty threshold) or your top field-specific journal (where specialty expertise may see novelty that generalists missed).

Rejected for methodology concerns? Fix the methodology before submitting anywhere. The same issues will surface at every peer-reviewed journal.

Rejected after review? Address reviewer concerns. PNAS, Science Advances, and field journals will benefit from revised data. Some will accept existing reviews as part of your submission.

Run your manuscript through a free Manusights scan to check formatting, structure, and scope alignment before your next submission.